Другие психические и неврологические расстройства.Goldberg SC, Schulz С, Schulz PM, et al. Borderline and schizotypal personality disorders treated with low-dose thiothixene vs. placebo. Arch Gen Psychiatry 1986; 43:680. Pfeiffer RF, Kang J, Graber B, et al. Clozapine for psychosis in Parkinson's disease. Mov Disord 1990; 5:239. Shapiro E, Shapiro AK, Fulop G, et al. Controlled study of haloperidol, pimozide, and placebo for the treatment of Gilles de la Tourette syndrome. Arch Gen Psychiatry 1989; 46:722. Атипичные антипсихотики.Alvir JMJ, Lieberman JA, Safferman AZ, et al. Clozapine-induced agranulocytosis: incidence and risk factors in the United States. N Engl J Med 1993; 329:162. Brier AF, Malhotra AK, Su T-P, et al. Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response. Am J Psychiatry 1999; 156:294. Kane J, Honigfeld G, Singer J, et al. The Clozaril Collaborative Study Group: clozapine for the treatment-resistant schizophrenic. A double-blind comparison vs. chlorpromazine/benztropine. Arch Gen Psychiatry 1988; 45:769. Sanger TM, Lieberman JA, Tohen M, et al. Olanzapine versus haloperidol treatment in first-episode psychosis. Am J Psychiatry 1999; 156:79. Small JG, Hirsch SR, Arvantis LA, et al. Quetiapine in patients with schizophrenia. Arch Gen Psychiatry 1997; 54:549. Wahlbeck K, Cheine M, Essali A, et al. Evidence of clozapine's effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials. Am J Psychiatry 1999; 156:990. Wirshing DA, Marshall BD, Green MF, et al. Risperidone in treatment-refractory schizophrenia. Am J Psychiatry 1999; 156:1374. Антипсихотики-депо.Carpenter WT Jr, Buchanan RW, Kirkpatrick B, et al. Comparative effectiveness of fluphenazine decanoate injections every 2 weeks versus every 6 weeks. Am J Psychiatry 1999; 156:412. Побочные эффекты и токсичность.Allison DB, Mentore JL, Heo M, et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999; 156:1686. Arana GW, Goff D, Baldessarini RJ, et al. The effect of anticholinergic prophylaxis on neuroleptic-induced dystonia. Am J Psychiatry 1988; 145:993. Casey DE. Side effect profiles of new antipsychotic agents. J Clin Psychiatry 1996; 57(suppl 11 ):40. Chouinard G, Annable L, Ross-Choiunard A, et al. A 5-year prospective longitudinal study of tardive dyskinesia: factors predicting appearance of new cases. J Clin Psychopharmacol 1988; 8(suppl):21. — 52 —
|